South Africa suspends 2 million Johnson & Johnson doses

Following a review of the FDA decision, the South African Health Products Regulatory Authority (SAHPRA) said in a statement that it had decided "not to release vaccine produced using the drug substance batches that were not suitable".

from News-Economic Times https://ift.tt/3pNNV2B

Related Posts:

0 Comments:

Post a Comment